_____________WHAT MAKES LERONLIMAB DIFFERENT?_____
Post# of 148110
Leronlimab is a UNIQUE... Monoclonal Antibody.
(a) Leronlimab PREVENTS HIV from using the CCR5 receptor as an
ENTRY gateway for healthy cells.
(b) Preclinical research has also shown that Leronlimab BLOCKS calcium
channel signalling of the CCR5 receptor when PRESENT on the cancer
cell surface.
(c) It is believed that calcium channel signalling of the CCR5 receptor is a
CRUCIAL component to the SPREAD of Metastic Cancer.
You put it all together...and it's part of the toolkit for future medicine.
I am wondering... When we'll hear on MDAnderson.